Oral cavity cancer constitutes two thirds of locally advanced head and neck cancer in India and majority presents in advanced stage. Despite aggressive treatment disease outcome is poor. The aim of this study is to compare concurrent chemo radiation with cisplatin and bleomycin versus concurrent chemo radiation with cisplatin alone in locally advanced oral cavity cancer. Materials and methods: Patients with locally advanced squamous cell carcinoma of oral cavity cancers registered at cancer institute from 2009 – 2011 were included in the study. Patients who were either taken up for initial surgery or treated with radiation therapy alone were excluded from study. Of 515 patients treated with concurrent chemo radiation, ...
AIM: The goal of the present work was to compare outcomes of definitive concurrent cisplatin-based c...
Background: Radical radiotherapy with concurrent high-dose cisplatin (100mg/m2/3 weeks) chemotherapy...
Background: The current standard of treatment for locally advanced cervical cancer is concurrent che...
Background: Concurrent chemo radiation is standard of care in locally advanced squamous cell carcino...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and to assess the toxicity...
AIM &OBJECTIVE: To evaluate and compare the immediate loco regional response rates in locally advan...
Background: Single-modality radiotherapy is still considered standard treatment for patients with lo...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and acute toxicity in patie...
Background: The purpose of this study was to compare the role of concomitant chemoradiation using pa...
BackgroundConcomitant chemoradiation is a widely used therapeutic concept in intensified locoregiona...
Background: Head and neck cancers constitute 6% of cancers worldwide. The management requires a mult...
Background: The aim of this study is to compare the outcomes of postoperative adjuvant concomitant c...
SummaryBackgroundConcomitant chemoradiation is a widely used therapeutic concept in intensified loco...
AIMS: In this retrospective analysis, we describe the efficacy and tolerability of weekly cisplatin...
Background: Concurrent chemoradiation is considered the standard care for locoregionally advanced no...
AIM: The goal of the present work was to compare outcomes of definitive concurrent cisplatin-based c...
Background: Radical radiotherapy with concurrent high-dose cisplatin (100mg/m2/3 weeks) chemotherapy...
Background: The current standard of treatment for locally advanced cervical cancer is concurrent che...
Background: Concurrent chemo radiation is standard of care in locally advanced squamous cell carcino...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and to assess the toxicity...
AIM &OBJECTIVE: To evaluate and compare the immediate loco regional response rates in locally advan...
Background: Single-modality radiotherapy is still considered standard treatment for patients with lo...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and acute toxicity in patie...
Background: The purpose of this study was to compare the role of concomitant chemoradiation using pa...
BackgroundConcomitant chemoradiation is a widely used therapeutic concept in intensified locoregiona...
Background: Head and neck cancers constitute 6% of cancers worldwide. The management requires a mult...
Background: The aim of this study is to compare the outcomes of postoperative adjuvant concomitant c...
SummaryBackgroundConcomitant chemoradiation is a widely used therapeutic concept in intensified loco...
AIMS: In this retrospective analysis, we describe the efficacy and tolerability of weekly cisplatin...
Background: Concurrent chemoradiation is considered the standard care for locoregionally advanced no...
AIM: The goal of the present work was to compare outcomes of definitive concurrent cisplatin-based c...
Background: Radical radiotherapy with concurrent high-dose cisplatin (100mg/m2/3 weeks) chemotherapy...
Background: The current standard of treatment for locally advanced cervical cancer is concurrent che...